The DOI matches its Crossref record; 32 of the 35 references it cites were found in a registry or an index.
Fibroblast Matrix Gene Expression and Connective Tissue Remodeling: Role of Endothelin-1
Open accessAbstract
This study examines endothelin-induced modulation of extracellular matrix synthesis and remodeling by fibroblasts, and its potential role in the pathogenesis of systemic sclerosis (scleroderma). Endothelin-1 promoted fibroblast synthesis of collagen types I and III, but not fibronectin, by a mechanism dependent upon both ETA and ETB receptors. Conversely, endothelin-1 inhibited both protein expression of matrix metalloproteinase 1 and zymographic activity exclusively via ETA receptors. A dual regulatory role for endothelin-1 in transcriptional regulation was suggested by the ability of endothelin-1 to enhance steady-state levels of collagen mRNA and activate the proalpha2(I) collagen (Col1a2) promoter, but in contrast to reduce matrix metalloproteinase 1 transcript expression and suppress transcription of a human matrix metalloproteinase 1 promoter reporter construct in transient transfection assays. Although endothelin-1 significantly enhanced remodeling of three-dimensional collagen lattices populated by normal fibroblasts, this was not observed for lattices populated by systemic sclerosis fibroblasts. Promotion of matrix remodeling was dependent upon ETA receptor expression and was blocked by specific inhibitors of tyrosine kinases or protein kinase C. Reverse transcriptase polymerase chain reaction, S1 nuclease, and functional cell surface binding studies showed that normal and systemic sclerosis fibroblasts express both ETA and ETB receptors (predominantly ETA), but that ETA receptor mRNA levels and ETA binding sites on fibroblasts cultured from systemic sclerosis skin biopsies are reduced by almost 50%. Endothelin-1 is thus able to induce a fibrogenic phenotype in normal fibroblasts that is similar to that of lesional systemic sclerosis fibroblasts. Moreover, reduced responsiveness to exogenous endothelin-1 in systemic sclerosis suggests that downstream pathways may have already been activated in vivo. These data further implicate dysregulated endothelin-receptor pathways in fibroblasts in the pathogenesis of connective tissue fibrosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The differentially regulated genes included several mediators of vascular wall integrity and structure, such as COL4A1, COL3A1, and FN1 (Figure S4E), which may be downstream effects of increased EDN1 expression in the G/G ESC-ECs (Amiri et al., 2004; Shi-Wen et al., 2001).”
From A Genetic Variant Associated with Five Vascular Diseases Is a Distal Regulator of Endothelin-1 Gene Expression (2017) · cites this paper as Shi-Wen et al., 2001
Citations
Cites
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,515
Preliminary criteria for the classification of systemic sclerosis (scleroderma)
Masi, A. T. (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230510 · Cited by 4,925
Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology.
Rubanyi, G. M., & Polokoff, M. A. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06809-7 · Cited by 1,645
Fibroblasts, myofibroblasts, and wound contraction
Grinnell, F. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.124.4.401 · Cited by 1,141
Levin, E. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508103330607 · Cited by 711
LeRoy, E. C. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107827 · Cited by 543
Hocher, B., Thöne‐Reineke, C., Rohmeiss, P., Schmager, F., Slowinski, T., Burst, V. R., Siegmund, F., Quertermous, T., Bauer, C., Neumayer, H.-H., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119297 · Cited by 411
Langholz, O., Roeckel, D., Mauch, C., Kozlowska, E., Bank, I., Krieg, T., & Eckes, B. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.131.6.1903 · Cited by 397
Barton, M., Haudenschild, C. C., d’Uscio, L. V., Shaw, S., Münter, K., & Lüscher, T. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14367 · Cited by 356
Effects of endothelins on collagen turnover in cardiac fibroblasts
Eduardo Guarda, S., Katwa, L. C., Myers, P. R., Tyagi, S. C., & Weber, K. T. (1993) · Cardiovascular Research · doi:10.1093/cvr/27.12.2130 · Cited by 291
Vancheeswaran, R., Magoulas, T., Efrat, G., Wheeler-Jones, C. P. D., Olsen, I., Penny, R., & Black, C. M. (1994) · PubMed · Cited by 239
Kahaleh, M. B. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780340807 · Cited by 234
Rockey, D. C., Fouassier, L., Chung, J. J., Carayon, A., Vallee, P. A. L., Rey, C., & Housset, C. (1998) · Hepatology · doi:10.1002/hep.510270222 · Cited by 231
Carvalho, D., Savage, C. O. S., Black, C. M., & Pearson, J. D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118377 · Cited by 222
Abraham, D., Vancheeswaran, R., Dashwood, M. R., Rajkumar, V. S., Pantelides, P., Xu, S. W., du Bois, R. M., & Black, C. M. (1997) · Europe PMC (PubMed Central) · Cited by 211
The Role of α1β1 Integrin in Wound Contraction
Racine-Samson, L., Rockey, D. C., & Bissell, D. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30911 · Cited by 176
Jiménez, S. A., Feldman, G. M., Bashey, R. I., Bienkowski, R. S., & Rosenbloom, J. (1986) · Biochemical Journal · doi:10.1042/bj2370837 · Cited by 169
Localization of endothelin-1 and its binding sites in scleroderma skin.
Vancheeswaran, R., Azam, A., Black, C. M., & Dashwood, M. R. (1994) · PubMed · Cited by 125
Regulation of Endothelin-1 Synthesis by Endothelin-converting Enzyme-1 during Wound Healing
Shao, R., Yan, W., & Rockey, D. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.5.3228 · Cited by 92
Mm, G., & Madhok, R. (1996) · PubMed · Cited by 83
Pagotto, U., Arzberger, T., Hopfner, Ú., Sauer, J., Renner, U., NEWTON, C. J., Lange, M., Uhl, E., Weindl, A., & Stalla, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118249 · Cited by 73
Endothelins produced by endothelial cells promote collagen gel contraction by fibroblasts.
Guidry, C., & Höök, M. (1991) · The Journal of Cell Biology · doi:10.1083/jcb.115.3.873 · Cited by 68
Ivarsson, M., McWhirter, A., Black, C. M., & Rubin, K. (1993) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12364810 · Cited by 59
Endothelin-1 Induces Increased Fibronectin Expression in Human Bronchial Epithelial Cells
Marini, M. A., Carpi, S., Bellini, A., Patalano, F., & Mattoli, S. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0502 · Cited by 57
Mutsaers, S. E., Marshall, R. P., Goldsack, N., Laurent, G. J., & McAnulty, R. J. (1998) · Pulmonary Pharmacology & Therapeutics · doi:10.1006/pupt.1998.0142 · Cited by 55
Biology of the scleroderma fibroblast
Strehlow, D., & Korn, J. H. (1998) · Current Opinion in Rheumatology · doi:10.1097/00002281-199811000-00011 · Cited by 55
Ichiki, Y., Smith, E. A., LeRoy, E. C., & Trojanowska, M. E. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12613617 · Cited by 31
Takeda, S., 澤芳樹, Minami, M., Kaneda, Y., Fujii, Y., Shirakura, R., Yanagisawa, M., & Matsuda, H. (1997) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(97)00367-6 · Cited by 30
Smith, P., Teichert-Kuliszewska, K., Monge, J. C., & Stewart, D. J. (1998) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199800001-00045 · Cited by 26
Scleroderma fibroblast phenotype is modulated by endothelial cell co-culture.
Denton, C. P., Xu, S., Welsh, K. I., Pearson, J. D., & Black, C. M. (1996) · PubMed · Cited by 21
Impaired Growth Response to Endothelin-1 in Scleroderma Fibroblasts
Kikuchi, K., Kadono, T., Sato, S., Tamaki, K., & Takehara, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1261 · Cited by 18
Blais (1997) · doi:10.1002/1529-0131(199707)40:7
Cited by
Sorted by citations
BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
King, T. E., Brown, K. K., Raghu, G., du Bois, R. M., Lynch, D. A., Martinez, F., Valeyre, D., Leconte, I., Morganti, A., Roux, S., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201011-1874oc · Cited by 718
Pulmonary Arterial Hypertension
McLaughlin, V. V., & McGoon, M. D. (2006) · Circulation · doi:10.1161/circulationaha.104.503540 · Cited by 667
The endothelin system in pulmonary arterial hypertension
Galiè, N. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.11.026 · Cited by 517
BUILD-1: A Randomized Placebo-controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
King, T. E., Behr, J., Brown, K. K., du Bois, R. M., Lancaster, L., de Andrade, J. A., Stähler, G., Leconte, I., Roux, S., & Raghu, G. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200705-732oc · Cited by 500
Gupta, R. M., Hadaya, J., Trehan, A., Zekavat, S. M., Roselli, C., Klarin, D., Emdin, C. A., Hilvering, C. R. E., Bianchi, V., Mueller, C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.049 · Cited by 450
Metadata
- Authors
- Shi-wen, X., Denton, C. P., Holmes, A. M., Black, C. M., Abraham, D. J., Dashwood, M. R., Bou-Gharios, G., & Pearson, J. D.
- Affiliations
- The Royal Free Hospital (GB)
- King's College London (GB)
- Corresponding author
- Abraham, David J.
- Venue
- Journal of Investigative Dermatology
- Publisher
- Elsevier BV
- Published
- 2001-03
- Volume
- 116
- Issue
- 3
- Pages
- 417-425
- ISSN
- 0022-202X (ISSN-L)
- OpenAlex
- W2064485592
- Cited by
- 243
- References
- 35
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 5 · 2023: 4 · 2022: 5 · 2021: 5 · 2020: 6 · 2019: 4 · 2018: 5 · 2017: 7 · 2016: 10 · 2015: 13 · 2014: 11 · 2013: 12 · 2012: 6
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of Investigative Dermatology (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- endothelin-1, systemic sclerosis, fibroblasts, extracellular matrix remodeling, collagen synthesis, type I collagen, type III collagen, fibronectin, MMP-1, ETA receptor, endothelin B receptor, connective tissue fibrosis, tyrosine kinase inhibitors, protein kinase C
- MeSH terms
- Cells, Cultured, Collagen, Connective Tissue, Extracellular Matrix, Fibroblasts, Humans, Reference Values, RNA, Messenger, Scleroderma, Systemic, Transcription, Genetic, Gene Expression, Receptors, Endothelin, Endothelin-1, Matrix Metalloproteinase 1, Receptor, Endothelin A, Receptor, Endothelin B
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review